Literature DB >> 6529525

Flurbiprofen interaction with single doses of atenolol and propranolol.

J Webster, J C Petrie, I McLean, G M Hawksworth.   

Abstract

In patients with mild hypertension, flurbiprofen in a dose of 100 mg daily for 7 days attenuated the hypotensive effect of a single dose of propranolol 80 mg but not of atenolol 100 mg. The attenuation was not due to an effect on the pharmacokinetic profile of either propranolol or atenolol. An alternative explanation is required.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6529525      PMCID： PMC1463692          DOI： 10.1111/j.1365-2125.1984.tb02556.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


  15 in total

1.  Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.

Authors:  H H Harms; L Gooren; A J Spoelstra; C Hesse; L Verschoor
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

2.  A sensitive gas chromatographic method for the determination of propranolol in human plasma.

Authors:  E Di Salle; K M Baker; S R Bareggi; W D Watkins; C A Chidsey; A Frigerio; P L Morselli
Journal:  J Chromatogr       Date:  1973-09-26

3.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

Authors:  F R Bühler; J H Laragh; L Baer; E D Vaughan; H R Brunner
Journal:  N Engl J Med       Date:  1972-12-14       Impact factor: 91.245

4.  Atenolol and bendrofluazide in hypertension.

Authors:  J C Petrie; D B Galloway; J Webster; W T Simpson; J A Lewis
Journal:  Br Med J       Date:  1975-10-18

5.  Failure of indomethacin to modify beta-adrenoceptor blockade.

Authors:  S R Smith; R Gibson; D Bradley; M J Kendall
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

6.  Modification of antihypertensive effect of beta-adrenoceptor-blocking agents by inhibition of endogenous prostaglandin synthesis.

Authors:  V Durão; M M Prata; L M Gonçalves
Journal:  Lancet       Date:  1977-11-12       Impact factor: 79.321

7.  The gas chromatographic determination of atenolol in biological samples.

Authors:  B Scales; P B Copsey
Journal:  J Pharm Pharmacol       Date:  1975-06       Impact factor: 3.765

8.  Cardiovascular and sympathetic response to exercise after long-term beta-adrenergic blockade.

Authors:  A E Raine; T G Pickering
Journal:  Br Med J       Date:  1977-07-09

9.  Prostaglandins are overproduced by the kidneys and mediate hyperreninemia in Bartter's syndrome.

Authors:  F C Bartter; J R Gill; J C Frolich; R E Bowden; J W Hollifield; N Radfar; H R Keiser; J A Oates; H Seyberth; A A Taylor
Journal:  Trans Assoc Am Physicians       Date:  1976

10.  Renin dependency of blood-pressure. Analysis by angiotensin II antagonist P113 in hypertensive patients treated with salt depletion and propranolol.

Authors:  G G Geyskes; P Boer; J Vos; E J Dorhout Mees
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321
View more
  8 in total

Review 1.  NSAIDs and blood pressure. Clinical importance for older patients.

Authors:  A G Johnson
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 2.  Drug interactions in hypertensive patients. Pharmacokinetic, pharmacodynamic and genetic considerations.

Authors:  Y W Lam; A M Shepherd
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

Review 3.  NSAIDs and increased blood pressure. What is the clinical significance?

Authors:  A G Johnson
Journal:  Drug Saf       Date:  1997-11       Impact factor: 5.606

Review 4.  Interactions of NSAIDs with diuretics and beta-blockers mechanisms and clinical implications.

Authors:  J Webster
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

5.  Ro 31-1118, a new cardioselective beta-adrenoceptor antagonist. Pharmacokinetics and effects on heart rate and blood pressure in mild hypertensives.

Authors:  M Jamieson; J C Petrie; J Webster; A Miller; R I Harris; R J Francis
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  A comparison of single doses of bucindolol and oxprenolol in hypertensive patients.

Authors:  J Webster; J C Petrie; O J Robb; M Jamieson; J Verschueren
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

Review 7.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

Review 8.  Clinical pharmacokinetics of flurbiprofen and its enantiomers.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.